Two Sigma Advisers
VYGR icon

Two Sigma Advisers’s Voyager Therapeutics VYGR Stock Holding History

Two Sigma Advisers’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-62,600
Closed -$246K – 2128
2025
Q4 		$246K Buy
62,600
+4,000
+7% +$17.7K ﹤0.01% 2047
2025
Q3 		$274K Buy
+58,600
New +$212K ﹤0.01% 2031
2024
Q2 		– Sell
-17,500
Closed -$163K – 2687
2024
Q1 		$163K Buy
17,500
+2,200
+14% +$18.6K ﹤0.01% 2243
2023
Q4 		$129K Sell
15,300
-7,000
-31% -$50.8K ﹤0.01% 2297
2023
Q3 		$173K Sell
22,300
-8,200
-27% -$74.9K ﹤0.01% 2121
2023
Q2 		$349K Sell
30,500
-4,600
-13% -$47.6K ﹤0.01% 1934
2023
Q1 		$271K Buy
35,100
+19,600
+126% +$156K ﹤0.01% 2176
2022
Q4 		$94.5K Sell
15,500
-16,800
-52% -$95.5K ﹤0.01% 2305
2022
Q3 		$191K Buy
32,300
+1,600
+5% +$10.2K ﹤0.01% 2215
2022
Q2 		$181K Buy
30,700
+17,200
+127% +$116K ﹤0.01% 2301
2022
Q1 		$103K Buy
+13,500
New +$60.2K ﹤0.01% 2501
2021
Q4 		– Sell
-30,800
Closed -$81K – 2821
2021
Q3 		$81K Sell
30,800
-82,800
-73% -$269K ﹤0.01% 2343
2021
Q2 		$469K Sell
113,600
-63,100
-36% -$286K ﹤0.01% 1965
2021
Q1 		$832K Buy
+176,700
New +$1.2M ﹤0.01% 1748
2020
Q4 		– Sell
-39,100
Closed -$417K – 2615
2020
Q3 		$417K Sell
39,100
-24,100
-38% -$283K ﹤0.01% 1889
2020
Q2 		$798K Sell
63,200
-8,600
-12% -$100K ﹤0.01% 1683
2020
Q1 		$657K Sell
71,800
-20,500
-22% -$235K ﹤0.01% 1681
2019
Q4 		$1.29M Buy
92,300
+7,300
+9% +$106K ﹤0.01% 1446
2019
Q3 		$1.46M Sell
85,000
-16,700
-16% -$351K ﹤0.01% 1252
2019
Q2 		$2.77M Buy
101,700
+1,600
+2% +$36.6K 0.01% 1069
2019
Q1 		$1.92M Buy
100,100
+900
+0.9% +$11.7K ﹤0.01% 1242
2018
Q4 		$932K Sell
99,200
-1,200
-1% -$15.4K ﹤0.01% 1517
2018
Q3 		$1.9M Buy
100,400
+3,000
+3% +$57.6K ﹤0.01% 1260
2018
Q2 		$1.9M Buy
97,400
+86,900
+828% +$1.72M 0.01% 1323
2018
Q1 		$197K Buy
+10,500
New +$227K ﹤0.01% 2154

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers's VYGR Position: Q1 2026 in Review

Two Sigma Advisers sold out of Voyager Therapeutics (VYGR) in Q1 2026, closing a stake of 62,600 shares — an estimated $246K sold.

Two Sigma Advisers first reported a position in VYGR in Q1 2018 and held it in 25 quarters. The position peaked at $2.77M in Q2 2019. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Two Sigma Advisers reported no remaining Voyager Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 62,600 Voyager Therapeutics shares in Q1 2026, an estimated $246K.
  • Two Sigma Advisers first reported a position in Voyager Therapeutics in Q1 2018 and held it in 25 quarters.
  • Two Sigma Advisers's Voyager Therapeutics position peaked at $2.77M in Q2 2019.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.